A. Seher

发表

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins

Joachim Nickel, W. Sebald, J. Nickel, 2009, BMC Biology.

Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.

A. Rosenwald, A. Mottok, H. Einsele, 2015, Blood.

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK

H. Wajant, M. Neumann, D. Siegmund, 2014, Front. Immunol..

Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway

N. Müller, H. Wajant, H. Kalthoff, 2010, The Journal of Immunology.

Connective Tissue Growth Factor Does Not Affect Transforming Growth Factor-Beta 1-Induced Smad3 Phosphorylation and T Lymphocyte Proliferation Inhibition

F. Jakob, A. Seher, C. Speer, 2008, International Archives of Allergy and Immunology.

sensitizes monocytes and maturing dendritic cells for tumor necrosis factor ( TNF )-dependent and-independent necroptosis 1 Running title : MLN 4924 sensitizes myeloid cells for necroptosis

H. Wajant, M. El-Mesery, T. Stühmer, 2014 .

Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells.

U. Müller-Richter, A. Kübler, H. Böhm, 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab

U. Müller-Richter, A. Kübler, C. Linz, 2016, Clinical Oral Investigations.

The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent

H. Wajant, J. Nickel, U. Müller-Richter, 2017, PloS one.

MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.

C. Scholz, U. Müller-Richter, C. Linz, 2019, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines

U. Müller-Richter, A. Kübler, C. Linz, 2016, Clinical Oral Investigations.

MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer

U. Müller-Richter, A. Kübler, H. Böhm, 2018, Clinical Oral Investigations.

Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

A. Mottok, H. Einsele, Carina A. Bäuerlein, 2016, The Journal of experimental medicine.

Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)*

D. Weisenberger, H. Wajant, A. Seher, 2011, The Journal of Biological Chemistry.

Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity*

D. Weisenberger, H. Wajant, D. Siegmund, 2013, The Journal of Biological Chemistry.

k Activate the Classical and Noncanonical NF-Weak Inducer of Apoptosis Differentially Soluble and Transmembrane TNF-Like

Harald, N. Müller, H. Kalthoff, 2010 .

MAGE-A expression clusters and antineoplastic treatment in head and neck cancer.

U. Müller-Richter, A. Kübler, C. Linz, 2015, International journal of molecular medicine.

Mass Spectrometric Metabolic Fingerprinting of 2-Deoxy-D-Glucose (2-DG)-Induced Inhibition of Glycolysis and Comparative Analysis of Methionine Restriction versus Glucose Restriction under Perfusion Culture in the Murine L929 Model System

M. El-Mesery, A. Kübler, A. Seher, 2022, International journal of molecular sciences.

Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine Restriction

M. El-Mesery, A. Kübler, A. Seher, 2021, International journal of molecular sciences.

Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand

A. Kotzsch, W. Sebald, J. Nickel, 2008, The FEBS journal.

Utilizing BMP-2 muteins for treatment of multiple myeloma

W. Sebald, J. Nickel, U. Müller-Richter, 2017, PloS one.

Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy

M. El-Mesery, A. Kübler, C. Linz, 2021, International journal of molecular sciences.

A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting - An in vitro study.

U. Müller-Richter, A. Kübler, C. Linz, 2019, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro

S. Kneitz, W. Sebald, J. Nickel, 2011, Molecular vision.

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor

A. Kotzsch, W. Sebald, J. Nickel, 2007, BMC Structural Biology.

Crystal structure analysis reveals a spring‐loaded latch as molecular mechanism for GDF‐5–type I receptor specificity

A. Kotzsch, W. Sebald, J. Nickel, 2009, The EMBO journal.

Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration – a pilot study in vitro

P. Dalton, G. Hochleitner, U. Müller-Richter, 2019, BMC Oral Health.

Evaluation of miRNA-expression and clinical tumour parameters in oral squamous cell carcinoma (OSCC).

C. Scholz, U. Müller-Richter, A. Kübler, 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings

Jonas Teusch, U. Müller-Richter, M. Bittrich, 2020, International journal of molecular sciences.

Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro.

U. Müller-Richter, A. Kübler, C. Linz, 2019, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab

U. Müller-Richter, A. Kübler, C. Linz, 2016, Clinical Oral Investigations.

Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.

U. Müller-Richter, A. Kübler, A. Seher, 2018, Oncology letters.

Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro

U. Müller-Richter, A. Kübler, A. Seher, 2019, Oncology letters.

MLN4924 sensitizes monocytes and maturing dendritic cells for TNF‐dependent and ‐independent necroptosis

H. Wajant, M. El-Mesery, T. Stühmer, 2015, British journal of pharmacology.

Opposing SMAD-6 and SMAD-7 Expression Profiles Correlate with the Sensitivity of Multiple Myeloma Cells to Bone Morphogenetic Protein (BMP)-2

J. Nickel, A. Seher, T. Müller, 2018 .

Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome*

Joachim Nickel, A. Kotzsch, W. Sebald, 2008, Journal of Biological Chemistry.

Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro.

U. Müller-Richter, A. Kübler, A. Seher, 2017, Oncology reports.

Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact Inhibition

M. El-Mesery, A. Kübler, C. Linz, 2022, Cells.

The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy

U. Müller-Richter, M. El-Mesery, A. Kübler, 2019, International journal of molecular sciences.

Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin‐induced sub‐G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells

M. El-Mesery, Mohamed El-Shafey, A. Seher, 2020, Biotechnology and applied biochemistry.

Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin.

U. Müller-Richter, A. Kübler, C. Linz, 2016, Molecular medicine reports.

Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines

U. Müller-Richter, A. Kübler, C. Linz, 2016, Clinical Oral Investigations.

Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro.

U. Müller-Richter, A. Kübler, C. Linz, 2020, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa

U. Müller-Richter, A. Kübler, C. Linz, 2017, Clinical Oral Investigations.

MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.

B. Polat, U. Müller-Richter, A. Kübler, 2018, Molecular and clinical oncology.

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma

M. Fischer, T. Bischler, U. Müller-Richter, 2020, International journal of molecular sciences.

Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.

U. Müller-Richter, A. Kübler, A. Seher, 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor

A. Kotzsch, W. Sebald, J. Nickel, 2007, BMC Structural Biology.

The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa

U. Müller-Richter, A. Kübler, C. Linz, 2016, Clinical Oral Investigations.

The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent

H. Wajant, J. Nickel, U. Müller-Richter, 2017, PloS one.

Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer

M. El-Mesery, A. Seher, J. Volland, 2023, Current issues in molecular biology.